[HTML][HTML] 3D bioprinting strategies, challenges, and opportunities to model the lung tissue microenvironment and its function
M Barreiro Carpio, M Dabaghi, J Ungureanu… - … in Bioengineering and …, 2021 - frontiersin.org
Human lungs are organs with an intricate hierarchical structure and complex composition;
lungs also present heterogeneous mechanical properties that impose dynamic stress on …
lungs also present heterogeneous mechanical properties that impose dynamic stress on …
Porcine lung-derived extracellular matrix hydrogel properties are dependent on pepsin digestion time
Hydrogels derived from decellularized lungs are promising materials for tissue engineering
in the development of clinical therapies and for modeling the lung extracellular matrix (ECM) …
in the development of clinical therapies and for modeling the lung extracellular matrix (ECM) …
3D bioprinting for tumor metastasis research
M Lin, M Tang, W Duan, S Xia, W Liu… - … Biomaterials Science & …, 2023 - ACS Publications
Tumor metastasis is a multiple cascade process where tumor cells disseminate from the
primary site to distant organs and subsequently adapt to the foreign microenvironment …
primary site to distant organs and subsequently adapt to the foreign microenvironment …
High-Fidelity Extrusion Bioprinting of Low-Printability Polymers Using Carbopol as a Rheology Modifier
M Barreiro Carpio, E Gonzalez Martinez… - … Applied Materials & …, 2023 - ACS Publications
Extrusion three-dimensional (3D) bioprinting is a promising technology with many
applications in the biomedical and tissue engineering fields. One of the key limitations for …
applications in the biomedical and tissue engineering fields. One of the key limitations for …
Engineering the alveolar gas exchange barrier with extracellular matrix coatings for bioengineered lungs
BM Young - 2019 - scholarscompass.vcu.edu
Lower respiratory diseases are currently the third leading cause of death worldwide. For
many end-stage patients with these diseases, there is no cure and a shortage of donor …
many end-stage patients with these diseases, there is no cure and a shortage of donor …